Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2
IA Kos, M Kiefer, K Brill, O Cetin… - Expert Review of …, 2022 - Taylor & Francis
Background Patients with cancer and autoimmune diseases are at higher risk of severe
COVID-19. They may not develop protective immune responses following vaccination. We …
COVID-19. They may not develop protective immune responses following vaccination. We …
Seroconversion rate of SARS-CoV-2 IgG antibodies and dating behaviour in HIV-PrEP users in a German metropolis during the COVID-19 pandemic
S Weidlich, J Schneider, M Lee… - … journal of STD & …, 2023 - journals.sagepub.com
Background At the beginning of the COVID-19 pandemic, when mortality was high, social
distance was the only option to prevent transmission of SARS-CoV-2 and prohibit …
distance was the only option to prevent transmission of SARS-CoV-2 and prohibit …
[HTML][HTML] SARS-CoV-2 seroprevalence in people living with HIV in South Sudan
HM Chun, DK Lodiongo, K Milligan, GJ Lesuk, D Patel… - IJID regions, 2024 - Elsevier
Objectives The burden of SARS-CoV-2 infection in people living with HIV (PLHIV) in South
Sudan is unknown. Methods We conducted a cross-sectional seroprevalence survey of …
Sudan is unknown. Methods We conducted a cross-sectional seroprevalence survey of …
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 Antibodies among People Living with HIV: A Cross-Sectional Study from Tripoli University …
NS Shalaka - Libyan Journal of Medical Sciences, 2021 - journals.lww.com
Seroprevalence of Severe Acute Respiratory Syndrome Coronavi... : Libyan Journal of Medical
Sciences Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 Antibodies …
Sciences Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 Antibodies …